Moreover, a trend toward higher sPD-L1 variation in IDH-mt (median: 1.71, range: 0.25–3.96) glioma was observed as compared to IDH-wt tumors (median: 0.77, range: 0–3.162; p = 0.149). Here, IDH1 is linked to central nervous system cancer.